By Emily Margosian, assistant editor

Since private equity’s debut into dermatology, its presence has sparked spirited debate among dermatologists about its impact on physician autonomy, patient care, and administrative burden. While Dermatology World has led discussions about the wider implications of a marriage between venture capital and health care (see July 2016’s “Skin in the game,” and January 2018’s “Pulling back the curtain on private equity”), a clear picture of the current size and scope of private equity’s influence can be elusive.

To help make sense of the steady pace of acquisitions, mergers, and occasional failed venture, this month Dermatology World presents a visual guide to the dermatology private equity landscape, by tracking:

• Regional influence

• The biggest deals in dermatology

• Key stats on major players

• Top 5 largest groups

• Year-by-year growth within the specialty

• Groups that have expanded the most 

Mapping out private equity ownership

While some private equity groups are regionally focused, others have a nationwide presence. See which groups are most prominent in your state.

BIGGEST DEALS IN DERMATOLOGY

While some private equity firms can have millions to billions of dollars’ worth of capital at their disposal, how much are they spending on dermatology? Check the chart below for some of the biggest dermatology deals. (Note: This list includes transactions whose financial terms were disclosed. Other transactions may have been larger.)